These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29588763)

  • 1. Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives.
    Mountfort K; Mahfoud F; Schmieder R; Davies J; Kandzari DE; Weil J; Whitbourn R
    Interv Cardiol; 2013 Aug; 8(2):118-123. PubMed ID: 29588763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Renal Denervation for Patients with Uncontrolled Hypertension in Taiwan: 3-Year Results From the Global SYMPLICITY Registry-Taiwan (GSR-Taiwan).
    Lee CK; Wang TD; Lee YH; Fahy M; Lee CH; Sung SH; Kao HL; Wu YW; Lin TH
    Acta Cardiol Sin; 2019 Nov; 35(6):618-626. PubMed ID: 31879514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation in resistant hypertension: a review of clinical trials and future perspectives.
    Yamamoto E; Sueta D; Tsujita K
    Cardiovasc Interv Ther; 2022 Jul; 37(3):450-457. PubMed ID: 35474179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
    Schlaich MP
    Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.
    Mahfoud F; Böhm M; Schmieder R; Narkiewicz K; Ewen S; Ruilope L; Schlaich M; Williams B; Fahy M; Mancia G
    Eur Heart J; 2019 Nov; 40(42):3474-3482. PubMed ID: 30907413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation for the treatment of hypertension and kidney disease.
    Camafort M; Ihm SH; Ruilope LM
    Curr Opin Nephrol Hypertens; 2023 Nov; 32(6):544-550. PubMed ID: 37706512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
    Persu A; Stoenoiu MS; Maes F; Kreutz R; Mancia G; Kjeldsen SE
    Clin Kidney J; 2023 Dec; 16(12):2357-2364. PubMed ID: 38046011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Denervation in the treatment of Resistant Hypertension.
    Yap LB; Balachandran K
    Med J Malaysia; 2021 Nov; 76(6):893-897. PubMed ID: 34806679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in renal denervation devices for resistant hypertension treatment.
    Haribabu S; Sharif F; Zafar H
    Ir J Med Sci; 2021 Aug; 190(3):971-979. PubMed ID: 33111251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation.
    Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
    Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry.
    Böhm M; Mahfoud F; Ukena C; Bauer A; Fleck E; Hoppe UC; Kintscher U; Narkiewicz K; Negoita M; Ruilope L; Rump LC; Schlaich M; Schmieder R; Sievert H; Weil J; Williams B; Zeymer U; Mancia G
    EuroIntervention; 2013 Aug; 9(4):484-92. PubMed ID: 23965354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal sympathetic denervation in the treatment of resistant hypertension.
    Sánchez-Álvarez C; González-Vélez M; Stilp E; Ward C; Mena-Hurtado C
    Yale J Biol Med; 2014 Dec; 87(4):527-35. PubMed ID: 25506285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
    Weber MA; Mahfoud F; Schmieder RE; Kandzari DE; Tsioufis KP; Townsend RR; Kario K; Böhm M; Sharp ASP; Davies JE; Osborn JW; Fink GD; Euler DE; Cohen DL; Schlaich MP; Esler MD
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1095-1105. PubMed ID: 31221299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation--hypes and hopes.
    Lewek J; Kaczmarek K; Pokushalov E; Romanov A; Cygankiewicz I; Ptaszynski P
    Cardiovasc Ther; 2015 Jun; 33(3):141-4. PubMed ID: 25786785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radio frequency-based renal denervation: a story of simplicity?
    Götzinger F; Kunz M; Lauder L; Mahfoud F; Böhm M
    Future Cardiol; 2023 Jul; 19(9):431-440. PubMed ID: 37791469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Renal Sympathetic Denervation for the Treatment of Hypertension.
    Rao A; Krishnan N
    Curr Cardiol Rep; 2022 Oct; 24(10):1261-1271. PubMed ID: 35895182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Artery Denervation for Hypertension.
    Ranard LS; Swaminathan RV
    Curr Treat Options Cardiovasc Med; 2019 Feb; 21(2):7. PubMed ID: 30762119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal arteries denervation with second generation systems: a remedy for resistant hypertension?
    Versaci F; Sciarretta S; Scappaticci M; Calcagno S; di Pietro R; Sbandi F; Dei Giudici A; Del Prete A; de Angelis S; Biondi-Zoccai G
    Eur Heart J Suppl; 2020 Nov; 22(Suppl L):L160-L165. PubMed ID: 33239993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.